Evidence map›Paper›PMID 39117115›Full record

ArticleActa biomaterialia2024

Engineered nanofibrillar collagen with tunable biophysical properties for myogenic, endothelial, and osteogenic cell guidance.

Yong How Tan, Krista M Habing, Jessica L Riesterer, Erin S Stempinski, Steven H Lewis, Carmem S Pfeifer, Sanjay V Malhotra, Karina H Nakayama

Abstract read
In one paragraph

Article in Acta biomaterialia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yong How TanDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Krista M HabingDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Jessica L RiestererCancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, OR, USA.
Erin S StempinskiMultiscale Microscopy Core, Oregon Health & Science University, Portland, OR, USA.
Steven H LewisBiomaterial and Biomedical Sciences, Oregon Health & Science University, Portland, OR, USA.
Carmem S PfeiferBiomaterial and Biomedical Sciences, Oregon Health & Science University, Portland, OR, USA.
Sanjay V MalhotraDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
Karina H NakayamaDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA; Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA. Electronic address: nakayaka@ohsu.edu.

Funding

Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
Regenerative engineering for complex extremity traumaR01AR080150 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Karina Nakayama · 2023 to 2026
$2.1M
Spatial patterning modulates tissue revascularization and regenerationR00HL136701 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NAKAYAMA, KARINA · 2020 to 2022
$741k
NCATS NIH HHS TL1 TR002371NHLBI NIH HHS R00 HL136701NIAMS NIH HHS R01 AR080150
6 · The paper itself

Abstract

A goal of regenerative engineering is the rational design of materials to restore the structure-function relationships that drive reparative programs in damaged tissues. Despite the widespread use of extracellular matrices for engineering tissues, their application has been limited by a narrow range of tunable features. The primary objective of this study is to develop a versatile platform for evaluating tissue-specific cellular interactions using Type I collagen scaffolds with highly tunable biophysical properties. The kinetics of collagen fibrillogenesis were modulated through a combination of varied shear rate and pH during neutralization, to achieve a broad range of fibril anisotropy, porosity, diameter, and storage modulus. The role that each of these properties play in guiding muscle, bone, and vascular cell types was comprehensively identified, and informed the in vitro generation of three distinct musculoskeletal engineered constructs. Myogenesis was highly regulated by smaller fibrils and larger storage moduli, endothelial inflammatory phenotype was predominantly guided by fibril anisotropy, and osteogenesis was enhanced by highly porous collagen with larger fibrils. This study introduces a novel approach for dynamically modulating Type I collagen materials and provides a robust platform for investigating cell-material interactions, offering insights for the future rational design of tissue-specific regenerative biomaterials. STATEMENT OF SIGNIFICANCE: The biophysical properties of regenerative materials facilitate key cell-substrate interactions that can guide the morphology, phenotype, and biological response of cells. In this study, we describe the fabrication of an engineered collagen hydrogel that can be modified to exhibit control over a wide range of biophysical features, including fibril organization and size, nanoscale porosity, and mechanics. We identified the unique combination of collagen features that optimally promote regenerative muscle, bone, and vascular cell types while also delineating the properties that hinder these same cellular responses. This study presents a highly accessible method to control the biophysical properties of collagen hydrogels that can be adapted for a broad range of tissue engineering and regenerative applications.

Indexed as

NanofibersOsteogenesisAnimalsCollagenCollagen Type IEndothelial CellsHumansMuscle DevelopmentTissue EngineeringTissue ScaffoldsCollagenCollagen Type IBiophysical modulationCollagen nanopatterningEndothelial cell inflammatory phenotypeMyogenesisOsteogenesis

Identifiers

PMID39117115
PMCPMC11407781

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.